Insider Transactions in Q3 2023 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2023
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,523
-1.35%
|
$52,845
$15.99 P/Share
|
|
Sep 26
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,517
-1.23%
|
$67,755
$15.99 P/Share
|
|
Sep 26
2023
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,402
-1.83%
|
$66,030
$15.99 P/Share
|
|
Sep 26
2023
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
858
-0.79%
|
$12,870
$15.99 P/Share
|
|
Sep 26
2023
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
133
-0.2%
|
$1,995
$15.99 P/Share
|
|
Sep 21
2023
|
Margaret Ancona SVP, Chief of Staff |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+14.23%
|
-
|
|
Sep 21
2023
|
Natalie Munk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+20.31%
|
-
|
|
Sep 21
2023
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,076
-0.41%
|
$17,216
$16.77 P/Share
|
|
Aug 25
2023
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-0.74%
|
$3,706
$17.7 P/Share
|
|
Aug 13
2023
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
74,235
-3.09%
|
$1,261,995
$17.89 P/Share
|